At SABCS, Mayo Clinic researchers reported PRS data was more likely to change the risk categories of people with variants in moderate risk penetrance genes.

Cervical cancer is the fourth most common cancer for women in the world, with more than 660,000 new cases and nearly 350,000 ...

Menopause after breast cancer can cause symptoms that substantially impact quality of life, making individualized, multidisciplinary care and shared decision-making critical, experts noted during ...

Gynecological malignancies constitute a rather significant health burden, worldwide, with an incidence rate of approximately 30.4 per 100,000 population.

Aromatase inhibitors demonstrated superior disease-free survival and time to distant recurrence compared to SERMs in HR+/HER2+ early breast cancer. The benefits of aromatase inhibitors were consistent ...

A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces of multiple myeloma after initial ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) seem to have little or no effect on obesity-related cancers, according ...

At the San Antonio Breast Cancer Symposium (SABCS), investigators reported final phase I results of an alpha-lactalbumin (aLA ...

Risk for suicide following a cancer diagnosis is increased among long-term survivors, according to study results published in The British Journal of Psychiatry. Based on previous research, ...

The MarketWatch News Department was not involved in the creation of this content. -- Collaboration leverages OBT's proprietary OGAP(R)-Verify platform and GSK's drug development expertise to advance ...

Researchers discovered that a long-misunderstood protein plays a key role in helping chromosomes latch onto the right “tracks” during cell division. Instead of acting like a motor, it works more like ...

Newswatch 16's Justin Gick spoke with a doctor about gynecological cancer and how early detection and access to care can save ...